Chengyi Sun

922 total citations
17 papers, 695 citations indexed

About

Chengyi Sun is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Chengyi Sun has authored 17 papers receiving a total of 695 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 7 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Chengyi Sun's work include Cancer Mechanisms and Therapy (5 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (4 papers). Chengyi Sun is often cited by papers focused on Cancer Mechanisms and Therapy (5 papers), MicroRNA in disease regulation (5 papers) and Cancer-related molecular mechanisms research (4 papers). Chengyi Sun collaborates with scholars based in China, Canada and United States. Chengyi Sun's co-authors include Chao Yu, Jianxin Jiang, Ling Chen, Lei Zhan, Shiyu Chen, Xingjun Guo, Zili Chen, Zhiwei He, Yaozhen Pan and Hong Zhang and has published in prestigious journals such as Medicine, Autophagy and Cell Death and Disease.

In The Last Decade

Chengyi Sun

17 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chengyi Sun China 13 424 326 171 132 109 17 695
Xiaoqian Jing China 19 442 1.0× 221 0.7× 185 1.1× 82 0.6× 105 1.0× 32 680
Qiuyang Chen China 15 464 1.1× 363 1.1× 225 1.3× 87 0.7× 152 1.4× 38 831
Xiquan Ke China 16 547 1.3× 472 1.4× 189 1.1× 79 0.6× 64 0.6× 33 855
Renhua Guo China 14 468 1.1× 251 0.8× 125 0.7× 62 0.5× 78 0.7× 35 637
Haihua Qian China 17 500 1.2× 311 1.0× 261 1.5× 54 0.4× 140 1.3× 29 828
So Mee Kwon South Korea 18 510 1.2× 337 1.0× 199 1.2× 113 0.9× 67 0.6× 29 892
Chuanyong Zhang China 13 382 0.9× 231 0.7× 156 0.9× 45 0.3× 125 1.1× 25 630
Guangyuan Song China 16 328 0.8× 210 0.6× 153 0.9× 94 0.7× 49 0.4× 47 621
Zhouyu Ning China 19 500 1.2× 357 1.1× 364 2.1× 61 0.5× 87 0.8× 40 911
Shucai Yang China 13 509 1.2× 317 1.0× 230 1.3× 44 0.3× 154 1.4× 24 793

Countries citing papers authored by Chengyi Sun

Since Specialization
Citations

This map shows the geographic impact of Chengyi Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chengyi Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chengyi Sun more than expected).

Fields of papers citing papers by Chengyi Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chengyi Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chengyi Sun. The network helps show where Chengyi Sun may publish in the future.

Co-authorship network of co-authors of Chengyi Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Chengyi Sun. A scholar is included among the top collaborators of Chengyi Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chengyi Sun. Chengyi Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Chen, Shiyu, et al.. (2021). Prodigiosin inhibits cholangiocarcinoma cell proliferation and induces apoptosis via suppressing SNAREs-dependent autophagy. Cancer Cell International. 21(1). 658–658. 11 indexed citations
2.
Zhan, Lei, et al.. (2021). miR‑660 promotes liver cancer cell proliferation by targeting PPP2R2A. Experimental and Therapeutic Medicine. 22(1). 683–683. 5 indexed citations
3.
Jiang, Jianxin, Chao Yu, Xingjun Guo, et al.. (2020). G Protein-Coupled Receptor GPR87 Promotes the Expansion of PDA Stem Cells through Activating JAK2/STAT3. Molecular Therapy — Oncolytics. 17. 384–393. 12 indexed citations
4.
Chen, Shiyu, Zhiwei He, Changhao Zhu, et al.. (2020). TRIM37 Mediates Chemoresistance and Maintenance of Stemness in Pancreatic Cancer Cells via Ubiquitination of PTEN and Activation of the AKT–GSK-3β–β-Catenin Signaling Pathway. Frontiers in Oncology. 10. 554787–554787. 17 indexed citations
5.
6.
He, Zhiwei, Xingjun Guo, Changhao Zhu, et al.. (2019). MicroRNA-137 reduces stemness features of pancreatic cancer cells by targeting KLF12. Journal of Experimental & Clinical Cancer Research. 38(1). 126–126. 47 indexed citations
7.
Chen, Zili, Yifei Ma, Shi Zuo, et al.. (2019). <p>Long Noncoding RNA RP5-833A20.1 Suppresses Tumorigenesis In Hepatocellular Carcinoma Through Akt/ERK Pathway By Targeting miR-18a-5p</p>. OncoTargets and Therapy. Volume 12. 10717–10726. 7 indexed citations
8.
Zhang, Hong, Yaozhen Pan, Chao Yu, et al.. (2019). LAMB3 mediates apoptotic, proliferative, invasive, and metastatic behaviors in pancreatic cancer by regulating the PI3K/Akt signaling pathway. Cell Death and Disease. 10(3). 230–230. 121 indexed citations
9.
Yu, Chao, et al.. (2018). Oncogenic TRIM31 confers gemcitabine resistance in pancreatic cancer via activating the NF-κB signaling pathway. Theranostics. 8(12). 3224–3236. 81 indexed citations
10.
Chen, Zili, Yifei Ma, Yaozhen Pan, et al.. (2018). MiR-1297 suppresses pancreatic cancer cell proliferation and metastasis by targeting MTDH. Molecular and Cellular Probes. 40. 19–26. 22 indexed citations
11.
Chen, Liwen, et al.. (2018). Combination of gemcitabine and erlotinib inhibits recurrent pancreatic cancer growth in mice via the JAK-STAT pathway. Oncology Reports. 39(3). 1081–1089. 27 indexed citations
12.
Chen, Liwen, et al.. (2017). MicroRNA-500a promotes migration and invasion in hepatocellular carcinoma by activating the Wnt/β-catenin signaling pathway. Biomedicine & Pharmacotherapy. 91. 13–20. 22 indexed citations
13.
Guo, Xingjun, et al.. (2016). miR-138-5p suppresses autophagy in pancreatic cancer by targetingSIRT1. Oncotarget. 8(7). 11071–11082. 70 indexed citations
14.
15.
Chen, Zili, et al.. (2016). LncRNA CRNDE promotes hepatic carcinoma cell proliferation, migration and invasion by suppressing miR-384.. PubMed. 6(10). 2299–2309. 96 indexed citations
16.
Jiang, Jianxin, et al.. (2015). TRIM37 promoted the growth and migration of the pancreatic cancer cells. Tumor Biology. 37(2). 2629–2634. 31 indexed citations
17.
Sun, Chengyi, et al.. (2014). A Meta-Analysis of the Effect of Preoperative Biliary Stenting on Patients With Obstructive Jaundice. Medicine. 93(26). e189–e189. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaoqian Jing Breakdown of academic impact, for papers by Qiuyang Chen Breakdown of academic impact, for papers by Xiquan Ke Breakdown of academic impact, for papers by Renhua Guo Breakdown of academic impact, for papers by Haihua Qian Breakdown of academic impact, for papers by So Mee Kwon Breakdown of academic impact, for papers by Chuanyong Zhang Breakdown of academic impact, for papers by Guangyuan Song Breakdown of academic impact, for papers by Zhouyu Ning Breakdown of academic impact, for papers by Shucai Yang
Rankless by CCL
2026